Non-alcoholic Steatohepatitis Clinical Trials Market Report 2022: Phase III Segment Dominated the Global Market in 2021
22 févr. 2022 05h08 HE
|
Research and Markets
Dublin, Feb. 22, 2022 (GLOBE NEWSWIRE) -- The "Non-alcoholic Steatohepatitis Clinical Trials Market Size, Share & Trends Analysis Report by Phase (Phase I, II, III, IV), by Study Design...
Mydecine Announces MYCO-005 Family of Improved Safety Microdose Novel Molecules
16 févr. 2022 07h30 HE
|
Mydecine Innovations Group Inc.
DENVER, Feb. 16, 2022 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), a biotechnology company aiming to transform the...
American Kidney Fund Launches Campaign to Engage Communities of Color to Participate in Kidney Disease Clinical Trials
15 févr. 2022 09h00 HE
|
American Kidney Fund
ROCKVILLE, Md., Feb. 15, 2022 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) today launched recently enhanced materials in its diversity in clinical trials patient education campaign to equip...
Global In Silico Clinical Trials Market Research Report 2022
10 févr. 2022 03h23 HE
|
Research and Markets
Dublin, Feb. 10, 2022 (GLOBE NEWSWIRE) -- The "Global In Silico Clinical Trials Market, By Industry (Medical Devices v/s Pharmaceuticals), By Therapeutic Area (Oncology, Neurology, Cardiology,...
NHS Cancer Alliance Implements Inspirata AI to Improve Clinical Trial Access for South West Patients
10 févr. 2022 02h59 HE
|
Inspirata, Inc.
Bristol, United Kingdom, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Cancer informatics and digital pathology provider Inspirata and the Somerset, Wiltshire, Avon and Gloucestershire Cancer Alliance (SWAG)...
Phathom Pharmaceuticals Announces Positive Topline Results from Phase 2 Trial Evaluating Vonoprazan for Non-Erosive Gastroesophageal Reflux Disease (NERD)
09 févr. 2022 16h04 HE
|
Phathom Pharmaceuticals
Vonoprazan met the primary endpoint for all three dose levels (10 mg, 20 mg, 40 mg) taken on-demand, demonstrating faster and sustained relief of episodic heartburn as compared to placebo...
LAG 3 Inhibitor Markets, 2028
04 févr. 2022 05h53 HE
|
Research and Markets
Dublin, Feb. 04, 2022 (GLOBE NEWSWIRE) -- The "Global LAG 3 Inhibitor Clinical Trials & Market Opportunity Insight 2028" report has been added to ResearchAndMarkets.com's offering. The emerging...
Global Clinical Trial Imaging Market Research Report (2021 to 2027) - by Product & Service, Modality, Therapeutic Area, End-user and Region
03 févr. 2022 09h03 HE
|
Research and Markets
Dublin, Feb. 03, 2022 (GLOBE NEWSWIRE) -- The "Clinical Trial Imaging Market Research Report by Product & Service, by Modality, by Therapeutic area, by End-User, by Region - Global Forecast to...
Worldwide AI-based Clinical Trials Solution Provider Industry to 2027 - Technological Advancements and Innovations in AI-Based Clinical Trials Presents Opportunities
03 févr. 2022 08h58 HE
|
Research and Markets
Dublin, Feb. 03, 2022 (GLOBE NEWSWIRE) -- The "AI-based Clinical Trials Solution Provider Market Research Report by Phase, by Application, by End User, by Region - Global Forecast to 2027 -...
Worldwide Clinical Trial Supplies Industry to 2027 - Increasing Demand for Innovative Solutions in Clinical Trials Services Presents Opportunities
03 févr. 2022 06h28 HE
|
Research and Markets
Dublin, Feb. 03, 2022 (GLOBE NEWSWIRE) -- The "Clinical Trial Supplies Market Research Report by Services, by Type, by Phase, by Therapeutic Area, by End User, by Region - Global Forecast to 2027 -...